Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

June 15, 2018

Study Completion Date

June 15, 2018

Conditions
Keloid
Interventions
DEVICE

The Lutronic electronic carbon dioxide (eCO2) Plus laser system

CO2 ablative laser plus intralesional triamcinolone acetonide A topical EMLA cream or tetracaine 7%/lidocaine 23% will be applied to the both treatment sites and after sufficient anesthesia is attained, one keloid will be treated with the fractional CO2 laser using standard protocol as practiced in our clinics followed by intralesional triamcinolone acetonide. One lesion would be treated with fractional CO2 ablative laser followed with intralesional triamcinolone acetonide at 4 weeks intervals

DRUG

Intralesional Triamcinolone Acetonide

Trial Locations (1)

21287

Johns Hopkins School of Medicine, Department of Dermatology, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT02996097 - Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids | Biotech Hunter | Biotech Hunter